|Last Price$9.16||Day Change (%)0.22%|
|Open Price$9.16||Day Change ($)0.02|
|Day Range9.16–9.16||52-Week Range8.59–9.27|
As of Tue 06/28/2016 | USD
Favorable conditions are in place for merger-arbitrage ETFs, including increasing M&A activity and the likelihood of higher interest rates.
Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.
We'd prefer a pack of gum to these businesses.
Three ways to separate long-term winners from stocks that fizzle.